MedTrace Logo

Screening for Breast Cancer With Digital Breast Tomosynthesis

NCT02698202 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26877

Last updated 2025-12-19

No results posted yet for this study

Summary

Randomized trial comparing the performance of tomosynthesis and 2D Digital Mammography vs 2D Digital Mammography only in respect to incidence of advanced cancers (interval and following round) and interval cancers.

Conditions

Interventions

DEVICE

Digital Breast Tomosynthesis

twice screening examination: standard 2D mammography + Digital Breast Tomosynthesis

Sponsors & Collaborators

  • Regione Emilia-Romagna

    collaborator OTHER

  • Azienda USL Reggio Emilia - IRCCS

    lead OTHER_GOV

Principal Investigators

  • Pierpaolo Pattacini, MD · Inter-Institutional Imaging Department, IRCCS-Arcispedale Santa Maria Nuova, Viale Umberto I 50, 42123, Reggio Emilia, Italy

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-10
Primary Completion
2017-07-31
Completion
2019-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698202 on ClinicalTrials.gov